The calls listed on this page are closed for the submission of full proposals (for single-stage calls) or short proposals (for two-stage calls). The status of each call is summarised below; for more information, please visit the individual call pages.
IHI call 1 is a single-stage call that was launched on 28 June 2022 with topics on cancer, neurodegenerative diseases, and health data.
Call status: The projects resulting from the call were launched in spring 2023.
IHI call 2 is a two-stage call that was launched 28 June 2022 with topics on cardiovascular disease and early feasibility studies.
Call status: The projects resulting from the call were launched in autumn 2023.
IHI call 3 is a single-stage call that was launched on 13 December 2022 with topics on a screening platform for diseases of unmet public health need; patient-generated evidence; hospital efficiencies; advanced therapies for rare diseases; and digital technologies for mental disorders.
Call status: The projects resulting from the call were launched in late 2023 / early 2024.
IHI call 4 is a two-stage call that was launched on 27 July 2023 with topics on the 3Rs, patient-centric blood sample collection, clinical trials, and the environmental impacts of healthcare.
Call status: The deadline for short proposals was 8 November 2023. Eligible proposals were evaluated by independent experts and the top-ranked consortia were invited to link up with the industry consortium described in the topic text and submit a full proposal by 23 April 2024. The full proposals have been evaluated by independent experts and grant agreement preparation is underway.
IHI call 5 is a single-stage call that was launched on 27 July 2023 with topics on the 3Rs, theranostics, stroke management and synthetic data.
Call status: The projects resulting from this call were launched in autumn 2024.
IHI call 6 is a two-stage call that was launched on 16 January 2024 with topics on treatment persistency and the use of real-world data and evidence.
Call status: The deadline for short proposals was 16 April 2024. Eligible proposals were evaluated by independent experts and the top-ranked consortia were invited to link up with the industry consortium described in the topic text and submit a full proposal by 10 October 2024.
IHI call 7 is a single-stage call that was launched on 16 January 2024 with topics on heart disease, the healthcare workforce, and biomarker validation.
Call status: The deadline for full proposals was 22 May 2024. Eligible proposals were evaluated by independent experts and grant agreement preparation is underway.
IHI call 8 is a two-stage call with topics on cardiovascular disease, osteoarthritis, regulatory sandboxes, and patient-centred endpoints.
Call status: The deadline for short proposals was 10 October 2024. Eligible proposals will be evaluated by independent experts and the top-ranked consortium from each topic will be invited to work with the pre-identified industry consortium and submit a full proposal by 23 April 2025.